Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Neratinib in Patients 60 and Older With HER2 Positive Metastatic Breast Cancer

NCT02673398 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT02673398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Neratinib in Patients 60 and Older With HER2 Positive Metastatic Breast Cancer
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Completed
Start date
December 2, 2016
Completion date
September 22, 2022
Enrollment
25 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

her2 positive breast carcinoma, stage iv breast cancer ajcc v6 and v7